rs9332971
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_000044.6(AR):c.2567G>A(p.Arg856His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000044.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Androgen resistance syndrome Pathogenic:4
- -
ACMG:PM1 PM2 PP3 PP4 -
- -
The patient is a 26-year-old phenotypically female with 46,XY karyotype, and typical symptoms of complete androgen insensitivity syndrome. The detected NM_000044.6:c.2567G>A p.(Arg856His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in populational databases. The in-silico tool predicts a pathogenic outcome for this variant. In a UniProt entity ANDR_HUMAN, there are 26 pathogenic changes around, and none are benign. The variant has been reported in ClinVar as pathogenic (5 submissions) and likely pathogenic (1 submission). UniProt lists this variant as pathogenic. Another variant affecting the same amino acid position but resulting in a different missense (i.e., Arg856Cys) has been classified as pathogenic in ClinVar. The variant was classified as pathogenic with 10 ACMG points (criteria: PS4_moderate, PM1, PM2, PM5, PP3, PP4). -
Androgen resistance syndrome;C1839259:Kennedy disease Pathogenic:1
Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant disrupts the p.Arg856 amino acid residue in AR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7581399, 24321103). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 9823). This variant is also known as R853H and 2926G>A (R855H). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 856 of the AR protein (p.Arg856His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with partial androgen insensitivity syndrome (PMID: 1430233, 8097257, 24737579). It has also been observed to segregate with disease in related individuals. -
Partial androgen insensitivity syndrome Pathogenic:1
- -
Male infertility Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at